SOLUX CORP has a total of 29 patent applications. Its first patent ever was published in 1954. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets organic fine chemistry, electrical machinery and energy and pharmaceuticals are RELIABLE BIOPHARMACEUTICAL CORP, GORDON PAUL and HUBEI LAOLONGDONG DUZHONG DEV CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 8 | |
#2 | United States | 7 | |
#3 | WIPO (World Intellectual Property Organization) | 7 | |
#4 | China | 6 | |
#5 | Australia | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Electrical machinery and energy | |
#3 | Pharmaceuticals | |
#4 | Civil engineering |
# | Technology | |
---|---|---|
#1 | Sugars | |
#2 | Therapeutic chemical compounds | |
#3 | Non-portable lighting devices | |
#4 | Special light sources | |
#5 | Medical preparations | |
#6 | Lighting device details | |
#7 | General building constructions |
# | Name | Total Patents |
---|---|---|
#1 | Matvienko Victor | 18 |
#2 | Itkin Aleksandr | 16 |
#3 | Zabudkin Alexander | 16 |
#4 | Matveev Alexey | 9 |
#5 | Matvyeyev Alexey | 9 |
#6 | Victor Matvienko | 6 |
#7 | Aleksandr Itkin | 5 |
#8 | Alexander Zabudkin | 5 |
#9 | Itkin Aleksandr M | 4 |
#10 | Alexey Matveev | 4 |
Publication | Filing date | Title |
---|---|---|
EP2342212A1 | Thermally stable crystalline epirubicin hydrochloride | |
US2009176974A1 | Method of aralkylation of 4′-hydroxyl group of anthracylins | |
EP1963348A2 | Synthesis of epirubicin from 13-dihydrodaunorubicine | |
WO2007070820A2 | Method for preparing 4-demethyldaunorubicin | |
US2006223766A1 | Epimerization of 4′-C bond and modification of 14-CH3-(CO)-fragment in anthracyclin antibiotics | |
EP1638509A2 | Thermally stable crystalline epirubicin hydrochloride and method of making the same | |
CN1791609A | Method of preparing 4-R-substituted 4-demethoxydaunorubicin | |
US7053191B2 | Method of preparing 4-R-substituted 4-demethoxydaunorubicin | |
WO03101483A1 | Pharmaceutical preparation of botulinum neurotoxin, methods of synthesis and methods of clinical use | |
US2879380A | Direct lighting equipment | |
US2762911A | Reflector for direct lighting equipment | |
US2713631A | Direct fluorescent lighting equipment |